Results 141 to 150 of about 7,304,651 (249)

Editorial: Recent Advances in Understanding the Pathogenesis of Shiga Toxin-Producing Shigella and Escherichia coli

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Moo-Seung Lee   +3 more
doaj   +1 more source

Inclusive Digital Health Strategies for Persons With Disabilities: A Scoping Review.

open access: yesJAMA Netw Open
Umucu E   +5 more
europepmc   +1 more source

Impact of Vaccination-Differentiated Public Health and Social Measures on Vaccine Uptake Among the Vaccine Hesitant. [PDF]

open access: yesAJPM Focus
Tan EJ   +9 more
europepmc   +1 more source

Characterizing the frequency of clinical events and assessing biomarkers in propionic acidemia: a natural history study. [PDF]

open access: yesOrphanet J Rare Dis
Schwahn BC   +20 more
europepmc   +1 more source

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. [PDF]

open access: yesJ Immunother Cancer
Brohl AS   +18 more
europepmc   +1 more source

What are the characteristics of the health and care workforce supporting people living with frailty in England now and what is needed for the future? A national survey. [PDF]

open access: yesBMJ Open
Fogg C   +10 more
europepmc   +1 more source

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy. [PDF]

open access: yesJCO Oncol Pract
Othus M   +19 more
europepmc   +1 more source

Ataxin-2 regulates the synaptonemal complex to ensure chromosome pairing during female meiosis. [PDF]

open access: yesGenetics
Monteiro VL   +8 more
europepmc   +1 more source

First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohort. [PDF]

open access: yesCancer Immunol Immunother
Ramadoss T   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy